FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

19439 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some
Members targetComponentId
Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 1.5 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection
Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 2 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for injection
Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 3 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection
Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 1.5 gram/1 liter conventional release solution for infusion bag Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection
Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 2 gram/1 liter conventional release solution for infusion bag Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for injection
Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 3 gram/1 liter conventional release solution for infusion bag Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection
Product containing precisely apraclonidine (as apraclonidine hydrochloride) 10 milligram/1 milliliter conventional release eye solution (clinical drug) Product containing precisely apraclonidine (as apraclonidine hydrochloride) 10 milligram/1 milliliter conventional release eye drops (clinical drug)
Product containing precisely argatroban monohydrate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Product containing precisely argatroban 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely argatroban monohydrate 250 milligram/2.5 milliliter conventional release solution for injection vial Product containing precisely argatroban 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Atorvastatin (as atorvastatin calcium) 10 mg oral tablet
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 20 milligram/1 each conventional release oral tablet (clinical drug) Atorvastatin (as atorvastatin calcium) 20 mg oral tablet
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 40 milligram/1 each conventional release oral tablet (clinical drug) Atorvastatin (as atorvastatin calcium) 40 mg oral tablet
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 80 milligram/1 each conventional release oral tablet (clinical drug) Atorvastatin (as atorvastatin calcium) 80 mg oral tablet
Product containing precisely atorvastatin 10 milligram/1 each conventional release oral tablet Atorvastatin (as atorvastatin calcium) 10 mg oral tablet
Product containing precisely atorvastatin 20 milligram/1 each conventional release oral tablet Atorvastatin (as atorvastatin calcium) 20 mg oral tablet
Product containing precisely atorvastatin 40 milligram/1 each conventional release oral tablet Atorvastatin (as atorvastatin calcium) 40 mg oral tablet
Product containing precisely atorvastatin 80 milligram/1 each conventional release oral tablet Atorvastatin (as atorvastatin calcium) 80 mg oral tablet
Product containing precisely atosiban (as atosiban acetate) 37.5 milligram/5 milliliter conventional release solution for infusion vial Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Product containing precisely azathioprine 50 milligram/1 vial powder for conventional release solution for injection Product containing precisely azathioprine (as azathioprine sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Product containing precisely azilsartan medoxomil 40 milligram/1 each conventional release oral tablet Azilsartan medoxomil (as azilsartan medoxomil potassium) 40 mg oral tablet
Product containing precisely azilsartan medoxomil 80 milligram/1 each conventional release oral tablet Product containing precisely azilsartan medoxomil (as azilsartan medoxomil potassium) 80 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely azithromycin (as azithromycin dihydrate) 250 milligram/1 each conventional release oral capsule Product containing precisely azithromycin 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) Azithromycin 500 mg oral tablet
Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 vial powder for conventional release solution for injection Azithromycin 500 mg powder for solution for injection vial
Product containing precisely azithromycin 10 milligram/1 milliliter conventional release eye solution (clinical drug) Azithromycin 10 mg/mL eye drops
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 10 milligram/1 milliliter conventional release eye solution (clinical drug) Azithromycin 10 mg/mL eye drops
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Product containing precisely azithromycin 20 milligram/1 milliliter conventional release oral suspension (clinical drug)
Product containing precisely azithromycin dihydrate 250 milligram/1 each conventional release oral tablet Product containing precisely azithromycin 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely azithromycin dihydrate 500 milligram/1 each conventional release oral tablet Azithromycin 500 mg oral tablet
Product containing precisely azithromycin dihydrate 600 milligram/1 each conventional release oral tablet Product containing precisely azithromycin 600 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely belimumab 120 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Product containing precisely belimumab 120 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Product containing precisely belimumab 400 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Belimumab 400 mg powder for solution for injection vial
Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet Betahistine dihydrochloride 16 mg oral tablet
Product containing precisely betahistine 8 milligram/1 each conventional release oral tablet Product containing precisely betahistine dihydrochloride 8 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely betamethasone dipropionate 640 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug)
Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) Betaxolol (as betaxolol hydrochloride) 2.5 mg/mL eye drops
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule
Product containing precisely bisoprolol 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet Product containing precisely bisoprolol fumarate 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely bisoprolol 2.5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet Bisoprolol fumarate 2.5 mg and hydrochlorothiazide 6.25 mg oral tablet
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet Product containing precisely bisoprolol fumarate 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely bosentan (as bosentan hydrochloride) 125 milligram/1 each conventional release oral tablet (clinical drug) Bosentan 125 mg oral tablet
Product containing precisely bosentan (as bosentan hydrochloride) 62.5 milligram/1 each conventional release oral tablet (clinical drug) Product containing precisely bosentan 62.5 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely bosutinib (as bosutinib monohydrate) 100 milligram/1 each conventional release oral tablet (clinical drug) Bosutinib 100 mg oral tablet
Product containing precisely bosutinib (as bosutinib monohydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) Bosutinib 500 mg oral tablet
Product containing precisely bosutinib monohydrate 100 milligram/1 each conventional release oral tablet Bosutinib 100 mg oral tablet
Product containing precisely bosutinib monohydrate 500 milligram/1 each conventional release oral tablet Bosutinib 500 mg oral tablet
Product containing precisely bromfenac (as bromfenac sodium) 900 microgram/1 milliliter conventional release eye solution (clinical drug) Product containing precisely bromfenac (as bromfenac sodium) 900 microgram/1 milliliter conventional release eye drops (clinical drug)
Product containing precisely bromocriptine 800 microgram/1 each conventional release oral tablet Product containing precisely bromocriptine (as bromocriptine mesilate) 800 microgram/1 each conventional release oral tablet (clinical drug)
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug)
Product containing precisely bupivacaine hydrochloride 312.5 milligram/250 milliliter conventional release solution for infusion bag Bupivacaine hydrochloride 1.25 mg/mL solution for injection
Product containing precisely buspirone 10 milligram/1 each conventional release oral tablet Buspirone hydrochloride 10 mg oral tablet
Product containing precisely buspirone 5 milligram/1 each conventional release oral tablet Buspirone hydrochloride 5 mg oral tablet
Product containing precisely canagliflozin (as canagliflozin hemihydrate) 100 milligram/1 each conventional release oral tablet (clinical drug) Canagliflozin 100 mg oral tablet
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Canakinumab 150 mg powder for solution for injection vial
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) Product containing precisely cannabidiol 25 milligram/1 milliliter and delta-9-tetrahydrocannabinol 27 milligram/1 milliliter conventional release oromucosal spray (clinical drug)
Product containing precisely carbenoxolone 20 milligram/1 gram conventional release oral gel (clinical drug) Carbenoxolone 20 mg/g oromucosal gel
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbidopa 25 milligram/1 each conventional release oral tablet Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbinoxamine 4 milligram/1 each conventional release oral tablet Carbinoxamine maleate 4 mg oral tablet
Product containing precisely carmellose 166 milligram/1 gram conventional release oral paste (clinical drug) Carmellose 166 mg/g oromucosal paste
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye solution (clinical drug) Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug)
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye solution (clinical drug) Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Product containing precisely cefaclor (as cefaclor monohydrate) 25 milligram/1 milliliter conventional release oral suspension Product containing precisely cefaclor anhydrous (as cefaclor) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)
Product containing precisely cefaclor (as cefaclor monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) Product containing precisely cefaclor 250 milligram/1 each conventional release oral capsule (clinical drug)
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug)
Product containing precisely cefaclor (as cefaclor monohydrate) 50 milligram/1 milliliter conventional release oral suspension Cefaclor 50 mg/mL oral suspension
Product containing precisely cefaclor (as cefaclor monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Cefaclor 500 mg oral capsule
Product containing precisely cefaclor anhydrous (as cefaclor) 250 milligram/1 each conventional release chewable tablet (clinical drug) Product containing precisely cefaclor 250 milligram/1 each conventional release chewable tablet (clinical drug)
Product containing precisely cefadroxil (as cefadroxil monohydrate) 100 milligram/1 milliliter conventional release oral suspension Cefadroxil 100 mg/mL oral suspension
Product containing precisely cefadroxil (as cefadroxil monohydrate) 25 milligram/1 milliliter conventional release oral suspension Cefadroxil 25 mg/mL oral suspension
Product containing precisely cefadroxil (as cefadroxil monohydrate) 50 milligram/1 milliliter conventional release oral suspension Cefadroxil 50 mg/mL oral suspension
Product containing precisely cefadroxil (as cefadroxil monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Product containing precisely cefadroxil 500 milligram/1 each conventional release oral capsule (clinical drug)
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) Product containing precisely cefalexin 250 milligram/1 each conventional release oral capsule (clinical drug)
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Product containing precisely cefalexin 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefalexin (as cefalexin monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Cefalexin 500 mg oral capsule
Product containing precisely cefalexin anhydrous (as cefalexin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) Cefalexin 25 mg/mL oral solution
Product containing precisely cefalexin hydrochloride 500 milligram/1 each conventional release oral tablet Cefalexin 500 mg oral tablet
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral capsule Product containing precisely cefalexin 250 milligram/1 each conventional release oral capsule (clinical drug)
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral tablet Product containing precisely cefalexin 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefalexin monohydrate 333 milligram/1 each conventional release oral capsule Cefalexin 333 mg oral capsule
Product containing precisely cefalexin monohydrate 500 milligram/1 each conventional release oral capsule Cefalexin 500 mg oral capsule
Product containing precisely cefalexin monohydrate 750 milligram/1 each conventional release oral capsule Cefalexin 750 mg oral capsule
Product containing precisely cefixime anhydrous (as cefixime) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) Cefixime 40 mg/mL oral suspension
Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Cefotaxime (as cefotaxime sodium) 2 g powder for solution for injection vial
Product containing precisely cefpodoxime 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Product containing precisely cefpodoxime (as cefpodoxime proxetil) 10 milligram/1 milliliter conventional release oral suspension (clinical drug)
Product containing precisely cefpodoxime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Product containing precisely cefpodoxime (as cefpodoxime proxetil) 20 milligram/1 milliliter conventional release oral suspension (clinical drug)

Start Previous Page 132 of 195 Next End

Reference Sets

Reference set descriptor

Back to Start